Codexis (LTS:0I0X) Total Liabilities : $70.29 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Codexis Total Liabilities?

Codexis's Total Liabilities for the quarter that ended in Mar. 2024 was $70.29 Mil.

Codexis's quarterly Total Liabilities declined from Sep. 2023 ($62.95 Mil) to Dec. 2023 ($49.95 Mil) but then increased from Dec. 2023 ($49.95 Mil) to Mar. 2024 ($70.29 Mil).

Codexis's annual Total Liabilities increased from Dec. 2021 ($81.99 Mil) to Dec. 2022 ($105.60 Mil) but then declined from Dec. 2022 ($105.60 Mil) to Dec. 2023 ($49.95 Mil).

Codexis Total Liabilities Historical Data

The historical data trend for Codexis's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Total Liabilities Chart

Codexis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

43.56

51.54

81.99

105.60

49.95

Codexis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															92.05	82.63	62.95	49.95	70.29

Codexis Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Codexis's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	35.83	+	(12.243	+	1.233
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.64	+	0)
	=	49.95

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	136.561	-	86.615
	=	49.95

Codexis's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	29.08	+	(39.334	+	1.248
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.63	+	0)
	=	70.29

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	149.559	-	79.267
	=	70.29

Codexis Total Liabilities Related Terms

Thank you for viewing the detailed overview of Codexis's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Codexis (LTS:0I0X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (LTS:0I0X) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CDXS:USA 4QK:Germany

Address

200 Penobscot Drive, Redwood, CA, USA, 94063

Website

https://www.codexis.com

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

Codexis (LTS:0I0X) Headlines

No Headlines